Jasleen Arneja1, Rayjean J Hung1,2, Ryan A Seeto2, Julia A Knight1,2, Sheryl L Hewko3, Alan Bocking2,3,4, Stephen J Lye2,3,4, Jennifer D Brooks5. 1. Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. 2. Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada. 3. Department of Obstetrics and Gynaecology, Sinai Health System, Toronto, ON, Canada. 4. Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada. 5. Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. jennifer.brooks@utoronto.ca.
Abstract
INTRODUCTION: Acetaminophen is the only analgesic recommended for use during pregnancy. This use has recently been linked to childhood developmental disorders, a finding that requires further investigation. Adverse birth outcomes-preterm birth, low birthweight, and small for gestational age-are associated with increased risk of developmental disorders and can serve as intermediate outcomes when examining the impact of maternal acetaminophen use. METHODS: Clinical and lifestyle-factor data were gathered from 1200 women within the Ontario Birth Study who delivered between January 2013 and June 2017. Poisson regression with robust error variance was used to estimate the relationship between acetaminophen use before and during pregnancy and low birthweight, preterm birth, and small for gestational age. RESULTS: Offspring of mothers who used acetaminophen before pregnancy had a higher risk of low birthweight and small for gestational age. Acetaminophen use <once/week was associated with small for gestational age, adjusted relative risk (aRR) = 1.46 (95% CI 1.02, 2.11). Acetaminophen use ≥once/week was associated with both small for gestational age, RR = 1.82 (95% CI 1.12, 2.94), and low birthweight, aRR = 2.16 (95% CI 1.02, 4.54). Acetaminophen use during pregnancy was not associated with the examined outcomes. CONCLUSIONS: Prepregnancy acetaminophen use may be associated with higher risk of adverse birth outcomes.
INTRODUCTION:Acetaminophen is the only analgesic recommended for use during pregnancy. This use has recently been linked to childhood developmental disorders, a finding that requires further investigation. Adverse birth outcomes-preterm birth, low birthweight, and small for gestational age-are associated with increased risk of developmental disorders and can serve as intermediate outcomes when examining the impact of maternal acetaminophen use. METHODS: Clinical and lifestyle-factor data were gathered from 1200 women within the Ontario Birth Study who delivered between January 2013 and June 2017. Poisson regression with robust error variance was used to estimate the relationship between acetaminophen use before and during pregnancy and low birthweight, preterm birth, and small for gestational age. RESULTS: Offspring of mothers who used acetaminophen before pregnancy had a higher risk of low birthweight and small for gestational age. Acetaminophen use <once/week was associated with small for gestational age, adjusted relative risk (aRR) = 1.46 (95% CI 1.02, 2.11). Acetaminophen use ≥once/week was associated with both small for gestational age, RR = 1.82 (95% CI 1.12, 2.94), and low birthweight, aRR = 2.16 (95% CI 1.02, 4.54). Acetaminophen use during pregnancy was not associated with the examined outcomes. CONCLUSIONS: Prepregnancy acetaminophen use may be associated with higher risk of adverse birth outcomes.
Authors: Kathryn A McInerney; Elizabeth E Hatch; Amelia K Wesselink; Kenneth J Rothman; Ellen M Mikkelsen; Lauren A Wise Journal: Hum Reprod Date: 2016-11-05 Impact factor: 6.918
Authors: Tracy A Manuck; Yunjia Lai; Hongyu Ru; Angelica V Glover; Julia E Rager; Rebecca C Fry; Kun Lu Journal: Am J Obstet Gynecol MFM Date: 2021-05-12